
|Articles|November 1, 2003
Single-dose Equivalency Seen
New York - California researchers have challenged the widespread belief among dermatologists that a "triple-dose" methotrexate regimen - in which three small doses of the potent drug are administered in 12-hour intervals -causes less liver toxicity than one large dose given once weekly.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
How AI Is Transforming Skin Cancer Diagnosis
2
Oral C5aR Inhibitor INF904 Shows Early Efficacy in HS and CSU Phase 2a Trials
3
Psoriasis Care Evolves as Oral IL-23 Blockers Show Lasting Control
4
Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters
5



















